Recent Advancements in Targeted Therapies

2019-03-07T16:19:27+00:00March 7th, 2019|Hot Topics|

The LCA Science and Research team just returned from the 2019 Targeted Therapies of Lung Cancer Meeting, and we have good news: treatment options continue to expand in the targeted therapies and immunotherapy space to treat all types of lung cancer. Here’s what we learned. All of the advancements presented emphasize the importance of molecular testing/biomarker testing so that the best treatments can be chosen for a patient’s unique cancer. There are currently approved targeted therapies for patients whose cancers [...]

Lung Cancer Advocacy: Why It Matters to Me

2018-06-12T13:51:48+00:00June 12th, 2018|Hot Topics, Stories of Hope|

During the more than three years since our youngest daughter, Katherine, was diagnosed with Stage 4 non-small cell lung cancer, we have joined forces to advocate for more funding for lifesaving research into why so many young women get lung cancer every year. Here we are at last fall’s rally in front of the U.S. Capitol, where we joined hundreds of other survivors, friends and families to declare that lung cancer is a national emergency. By U.S. Congressman Rick [...]

LCA Supports Research to Treatment Pathways for Small Cell Lung Cancer

2018-06-08T19:30:51+00:00June 4th, 2018|Hot Topics, News|

Monday, June 4, 2018 --Today, Lung Cancer Alliance (LCA) is proud to announce Carl M. Gay, MD, PhD as the recipient of the 2018 Conquer Cancer Foundation of ASCO/Lung Cancer Alliance Young Investigator Award (YIA). Through this award, LCA will support Dr. Gay’s research into whether inhibiting DNA repair mechanisms in small cell lung cancer can either lead to cancer death or increase the ability for immunotherapies to work better to fight the cancer. Conquer Cancer Foundation formally announced the [...]